Athira Pharma’s experimental Alzheimer’s drug fosgonimeton hit a speedbump on its way toward FDA approval: The treatment failed to show a clinical benefit in … Continue reading Athira’s Alzheimer’s Drug Fails in Later-stage Clinical Trial